Why Navidea Biopharmaceuticals Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket



  • CXApp Inc. CXAI jumped 318% to $29.80 in pre-market trading after gaining more than 345% on Thursday.
  • SAI.TECH Global Corporation SAI gained 211% to $4.73 in pre-market trading after gaining around 25% on Thursday.
  • Inpixon INPX surged 106% to $1.49 in pre-market trading after jumping around 128% on Thursday.
  • Petros Pharmaceuticals, Inc. PTPI climbed 98.2% to $2.24 in pre-market trading.
  • SMX (Security Matters) Public Limited Company SMX shares climbed 54.3% to $3.50 in pre-market trading after jumping 37% on Thursday.
  • Marpai, Inc. MRAI gained 41% to $2.30 in pre-market trading after gaining 90% on Thursday.
  • LogicMark, Inc. LGMK gained 24.7% to $0.1970 in pre-market trading after gaining around 8% on Thursday.
  • G Medical Innovations Holdings Ltd GMVD gained 23.7% to $0.6572 in pre-market trading. G Medical Innovations recently announced closing of public offering.
  • Navidea Biopharmaceuticals, Inc. NAVB gained 16.5% to $0.3035 in pre-market trading. Navidea Biopharmaceuticals entered into $750,000 asset purchase agreement with Meilleur Technologies for rights to NAV4694.
  • Freight Technologies, Inc. FRGT climbed 15.7% to $3.02 in pre-market trading after declining 9% on Thursday. Freight Technologies recently regained compliance with Nasdaq listing rule.


  • Navidea Biopharmaceuticals NCMI fell 27% to $0.3124 in pre-market trading. The company recently filed a voluntary Chapter 11 petition in the U.S. Bankruptcy Court for the Southern District of Texas. The company announced a series of debt restructuring transactions likely to strengthen its balance sheet meaningfully and position it for long-term growth.
  • Pear Therapeutics, Inc. PEAR shares dropped 24.4% to $0.0896 in pre-market trading. Pear Therapeutics recently filed for Chapter 11 and said it will seek to sell its assets through a sales process.
  • PARTS iD, Inc. ID fell 21.9% to $0.1926 in pre-market after dropping over 5% on Thursday.
  • SAB Biotherapeutics, Inc. SABS fell 20.5% to $0.6029 in pre-market trading. SAB Therapeutics shares jumped around 98% on Thursday after the company said it has been granted Fast Track designation from the FDA for SAB-176 influenza immunotherapy with high cross-reactivity to multiple strains of influenza.
  • Meta Materials Inc. MMAT fell 20.2% to $0.3050 in pre-market trading after the company reported a proposed public offering.
  • Panbela Therapeutics, Inc. PBLA fell 18.8% to $0.47 in pre-market trading. Panbela Therapeutics recently announced the first patient has been enrolled in the Phase II trial of CPP-1X-T.
  • Kalera Public Limited Company KAL fell 17.3% to $1.34 in pre-market trading after dropping 14% on Thursday. Kalera recently received a notice of delisting form Nasdaq.
  • Wheels Up Experience Inc. UP fell 17.1% to $0.44 in pre-market trading after gaining around 27% on Thursday.
  • HeartCore Enterprises, Inc. HTCR fell 15.1% to $1.01 in pre-market trading after dropping 15% on Thursday. HeartCore Enterprises recently announced it signed its tenth Go IPO contract.
  • Knightscope, Inc. KSCP shares fell 13.6% to $0.55 in pre-market trading after dropping over 6% on Thursday.

Now Read This: S&P 500 Settles Higher Ahead Of Bank Earnings, Market Volatility Decreases

Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksPre-Market OutlookMarketsMoversTrading IdeasPremarket MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!